This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Johnson & Johnson
Drug Names(s): RWJ-445380
Description: RWJ-445380 is a cathepsin S inhibitor. Cathepsin S is a cysteine protease which is expressed in certain antigen presenting cells and has been implicated in the presentation of antigens to CD4+ T cells. Inhibition of cathepsin S may reduce antigen presentation within certain antigen presenting cells.
Deal Structure: On June 22, 2001, ALZA Corporation became a wholly owned subsidiary of Johnson & Johnson.
Pink Sheet Office for Human Research Trials
Additional information available to subscribers only: